TFS Capital’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-18,850
Closed -$162K 786
2016
Q4
$162K Buy
+18,850
New +$161K 0.04% 569
2016
Q3
Sell
-89,892
Closed -$723K 904
2016
Q2
$723K Buy
+89,892
New +$721K 0.13% 260
2016
Q1
Sell
-10,114
Closed -$80K 1064
2015
Q4
$80K Buy
+10,114
New +$74.1K 0.01% 676
2015
Q3
Sell
-134,225
Closed -$726K 996
2015
Q2
$726K Sell
134,225
-257,113
-66% -$1.33M 0.07% 415
2015
Q1
$1.83M Sell
391,338
-150,893
-28% -$656K 0.18% 159
2014
Q4
$2.26M Sell
542,231
-322,861
-37% -$1.48M 0.22% 123
2014
Q3
$4.51M Buy
865,092
+703,199
+434% +$3.61M 0.39% 38
2014
Q2
$537K Sell
161,893
-518
-0.3% -$1.72K 0.04% 619
2014
Q1
$564K Buy
162,411
+51,109
+46% +$191K 0.04% 682
2013
Q4
$403K Buy
111,302
+99,568
+849% +$346K 0.02% 934
2013
Q3
$35K Buy
+11,734
New +$33.1K ﹤0.01% 1396

Other funds holding NEO

TFS Capital's NEO Position: Q1 2017 in Review

TFS Capital sold out of NeoGenomics (NEO) in Q1 2017, closing a stake of 18,850 shares — an estimated $162K sold.

TFS Capital first reported a position in NEO in Q3 2013 and held it in 11 quarters. The position peaked at $4.51M in Q3 2014. 143 funds tracked by Wall St. Rank hold NEO as of Q1 2017.

  • TFS Capital reported no remaining NeoGenomics position as of Q1 2017 after selling out during the quarter.
  • TFS Capital sold 18,850 NeoGenomics shares in Q1 2017, an estimated $162K.
  • TFS Capital first reported a position in NeoGenomics in Q3 2013 and held it in 11 quarters.
  • TFS Capital's NeoGenomics position peaked at $4.51M in Q3 2014.
  • 143 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2017.

Based on TFS Capital's 13F filing for Q1 2017, filed 5 May 2017.